What question did this study set out to answer?

This research aims to explore how melatonin protects against ovarian toxicity caused by cisplatin treatment in mice through receptor and antioxidant mechanisms.

June 1, 2017Biology of Reproduction

Melatonin protects against cisplatin-induced ovarian damage in mice via the MT1 receptor and antioxidant activity†

View Full Paper

Ask AI

Bookmark

This research aims to explore how melatonin protects against ovarian toxicity caused by cisplatin treatment in mice through receptor and antioxidant mechanisms.
Mice received melatonin pretreatment at doses of 5, 10, or 20 mg/kg before cisplatin administration for three days.
The MT1 and MT2 receptor contributions were assessed using specific antagonists administered prior to treatment.
Ovaries were collected for histological and immunohistochemical analysis to evaluate morphological and oxidative stress responses.
Melatonin at 20 mg/kg preserved normal follicular morphology and decreased apoptosis compared to cisplatin alone.
Increased levels of glutathione and reduced mitochondrial damage were observed with melatonin treatment.
The nonselective MT1/MT2 antagonist blocked the protective effects, whereas the selective MT2 antagonist did not affect melatonin's efficacy.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Randomized trial evaluates melatonin's protective effects against ovarian damage from cisplatin in mice, indicating its potential therapeutic role.

Cite This Study

Barberino et al. (2017) studied this question.

synapsesocial.com/papers/6a1da630a25575e2d9ce2231 https://doi.org/10.1093/biolre/iox053

View Full Paper

Ask AI

Bookmark

Implication

Randomized trial evaluates melatonin's protective effects against ovarian damage from cisplatin in mice, indicating its potential therapeutic role.

Melatonin protects against cisplatin-induced ovarian damage in mice via the MT1 receptor and antioxidant activity†

Key Points

Discussion

Implication

Cite This Study

Melatonin protects against cisplatin-induced ovarian damage in mice via the MT1 receptor and antioxidant activity†

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider